PortfoliosLab logoPortfoliosLab logo
AVNS vs. KMB
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

AVNS vs. KMB - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Avanos Medical, Inc. (AVNS) and Kimberly-Clark Corporation (KMB). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, AVNS achieves a 122.44% return, which is significantly higher than KMB's -4.92% return. Over the past 10 years, AVNS has underperformed KMB with an annualized return of -2.53%, while KMB has yielded a comparatively higher 0.29% annualized return.


AVNS

1D
-0.04%
1M
1.30%
YTD
122.44%
6M
120.87%
1Y
100.64%
3Y*
0.20%
5Y*
-8.59%
10Y*
-2.53%

KMB

1D
-2.80%
1M
-0.93%
YTD
-4.92%
6M
-8.51%
1Y
-29.05%
3Y*
-7.87%
5Y*
-2.82%
10Y*
0.29%
*Multi-year figures are annualized to reflect compound growth (CAGR)

AVNS vs. KMB - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
AVNS
Avanos Medical, Inc.
122.44%-29.46%-29.02%-17.11%-21.95%-24.43%36.14%-24.76%-3.01%24.88%
KMB
Kimberly-Clark Corporation
-4.92%-19.86%11.79%-7.08%-1.58%9.66%0.95%24.57%-2.06%9.04%

Correlation

The correlation between AVNS and KMB is 0.17, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.17

Correlation (3Y)
Calculated over the trailing 3-year period

0.19

Correlation (5Y)
Calculated over the trailing 5-year period

0.22

Correlation (10Y)
Calculated over the trailing 10-year period

0.17

Correlation (All Time)
Calculated using the full available price history since Oct 22, 2014

0.18

Fundamentals

EPS

AVNS:

-$1.99

KMB:

$5.93

PS Ratio

AVNS:

1.22

KMB:

1.91

Total Revenue (TTM)

AVNS:

$715.90M

KMB:

$16.54B

Gross Profit (TTM)

AVNS:

$353.40M

KMB:

$5.93B

EBITDA (TTM)

AVNS:

-$29.60M

KMB:

$3.07B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

AVNS vs. KMB — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

AVNS
AVNS Risk / Return Rank: 8888
Overall Rank
AVNS Sharpe Ratio Rank: 7878
Sharpe Ratio Rank
AVNS Sortino Ratio Rank: 9393
Sortino Ratio Rank
AVNS Omega Ratio Rank: 9393
Omega Ratio Rank
AVNS Calmar Ratio Rank: 8989
Calmar Ratio Rank
AVNS Martin Ratio Rank: 8989
Martin Ratio Rank

KMB
KMB Risk / Return Rank: 44
Overall Rank
KMB Sharpe Ratio Rank: 22
Sharpe Ratio Rank
KMB Sortino Ratio Rank: 55
Sortino Ratio Rank
KMB Omega Ratio Rank: 44
Omega Ratio Rank
KMB Calmar Ratio Rank: 22
Calmar Ratio Rank
KMB Martin Ratio Rank: 55
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

AVNS vs. KMB - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Avanos Medical, Inc. (AVNS) and Kimberly-Clark Corporation (KMB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


AVNSKMBDifference
Sharpe ratioReturn per unit of total volatility

+2.47

Sortino ratioReturn per unit of downside risk

+5.12

Omega ratioGain probability vs. loss probability

1.51

0.78

+0.73

Calmar ratioReturn relative to maximum drawdown

4.33

-0.98

+5.30

Martin ratioReturn relative to average drawdown

11.06

-1.51

+12.57

AVNS vs. KMB - Sharpe Ratio Comparison

The current AVNS Sharpe Ratio is 1.30, which is higher than the KMB Sharpe Ratio of -1.17. The chart below compares the historical Sharpe Ratios of AVNS and KMB, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


AVNSKMBDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.30

-1.17

+2.47

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.18

-0.14

-0.04

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

-0.06

0.01

-0.07

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.10

0.46

-0.55

Drawdowns

AVNS vs. KMB - Drawdown Comparison

The maximum AVNS drawdown since its inception was -86.39%, which is greater than KMB's maximum drawdown of -36.97%. Use the drawdown chart below to compare losses from any high point for AVNS and KMB.


Loading charts...

Drawdown Indicators


AVNSKMBDifference

Max Drawdown

Largest peak-to-trough decline

-86.39%

-36.97%

-49.42%

Max Drawdown (1Y)

Largest decline over 1 year

-23.39%

-29.79%

+6.40%

Max Drawdown (3Y)

Largest decline over 3 years

-62.41%

-34.06%

-28.35%

Max Drawdown (5Y)

Largest decline over 5 years

-75.55%

-34.06%

-41.49%

Max Drawdown (10Y)

Largest decline over 10 years

-86.39%

-34.06%

-52.33%

Current Drawdown

Current decline from peak

-65.62%

-32.85%

-32.77%

Average Drawdown

Average peak-to-trough decline

-47.04%

-8.84%

-38.20%

Ulcer Index

Depth and duration of drawdowns from previous peaks

9.13%

19.81%

-10.68%

Volatility

AVNS vs. KMB - Volatility Comparison

The current volatility for Avanos Medical, Inc. (AVNS) is 1.36%, while Kimberly-Clark Corporation (KMB) has a volatility of 6.43%. This indicates that AVNS experiences smaller price fluctuations and is considered to be less risky than KMB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


AVNSKMBDifference

Volatility (1M)

Calculated over the trailing 1-month period

1.36%

6.43%

-5.07%

Volatility (6M)

Calculated over the trailing 6-month period

57.06%

15.33%

+41.73%

Volatility (1Y)

Calculated over the trailing 1-year period

77.95%

24.88%

+53.07%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

48.00%

19.95%

+28.05%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

44.65%

20.96%

+23.69%

Dividends

AVNS vs. KMB - Dividend Comparison

AVNS has not paid dividends to shareholders, while KMB's dividend yield for the trailing twelve months is around 5.34%.


PositionTTM20252024202320222021202020192018201720162015
AVNS
Avanos Medical, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
KMB
Kimberly-Clark Corporation
5.34%5.00%3.72%3.88%3.42%3.19%3.17%3.00%3.51%3.22%3.22%2.77%

Financials

AVNS vs. KMB - Financials Comparison

This section allows you to compare key financial metrics between Avanos Medical, Inc. and Kimberly-Clark Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.001.00B2.00B3.00B4.00B5.00B20222023202420252026
182.20M
4.16B
(AVNS) Total Revenue
(KMB) Total Revenue
Values in USD except per share items

AVNS vs. KMB - Profitability Comparison

The chart below illustrates the profitability comparison between Avanos Medical, Inc. and Kimberly-Clark Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

25.0%30.0%35.0%40.0%45.0%50.0%55.0%60.0%20222023202420252026
51.7%
36.9%
Portfolio components
AVNS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Avanos Medical, Inc. reported a gross profit of 94.20M and revenue of 182.20M. Therefore, the gross margin over that period was 51.7%.

KMB - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Kimberly-Clark Corporation reported a gross profit of 1.53B and revenue of 4.16B. Therefore, the gross margin over that period was 36.9%.

AVNS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Avanos Medical, Inc. reported an operating income of 8.90M and revenue of 182.20M, resulting in an operating margin of 4.9%.

KMB - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Kimberly-Clark Corporation reported an operating income of 753.00M and revenue of 4.16B, resulting in an operating margin of 18.1%.

AVNS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Avanos Medical, Inc. reported a net income of 5.10M and revenue of 182.20M, resulting in a net margin of 2.8%.

KMB - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Kimberly-Clark Corporation reported a net income of 521.00M and revenue of 4.16B, resulting in a net margin of 12.5%.


Frequently Asked Questions


AVNS and KMB have a correlation of 0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

KMB has higher volatility (6.43%) compared to AVNS (1.36%). In terms of maximum drawdown, AVNS dropped -86.39% vs KMB's -36.97%.

AVNS currently has the higher Sharpe Ratio (1.30 vs -1.17), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for AVNS and KMB

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer